Author Archives: NLObserver Team

Nasdaq 100 Watch List

The following are the Nasdaq 100 members that are within 20% of the 52-week low:

  • Apollo Group, Inc. (APOL) at $53.86 within 2.03%
  • Cephalon, Inc. (CEPH) at $59.81 within 13.82%
  • Genzyme Corporation (GENZ) at $49.28 within 4.65%
  • Pharma. Products Dev. (PPDI) at $20.66 within 14.97%
  • Gilead Sciences, Inc. (GILD) at $47.05 within 19.51%

Dividend Achiever Watch List,

The market closed above 10,000 for two consecutive weeks at 10,270.47, up 2.4% from prior week. At the end of the week, my watch list expanded to 19 companies compared to 17 from the previous week due in part because of an addition of regional banks. Here are the companies on my watch list as of November 13, 2009.
Symbol
Name
Price
P/E
% Yr Low
Yield
EPS
Div/Shr
Payout Ratio
THFF
First Financial Corporation
27.23
14.80
1.91%
3.31%
1.84
0.90
49%
WTR
AQUA AMERICA INC
15.84
20.84
2.92%
3.66%
0.76
0.58
76%
SHEN
Shenandoah Telecom
16.88
27.23
4.84%
1.90%
0.62
0.32
52%
CWT
CALIFORNIA WATER SVC
35.28
17.82
5.34%
3.34%
1.98
1.18
60%
PNY
PIEDMONT NAT GAS CO
22.86
14.75
10.54%
4.72%
1.55
1.08
70%
WGL
WGL HOLDINGS INC
31.89
13.34
11.54%
4.61%
2.39
1.47
62%
WEYS
Weyco Group, Inc.
22.48
22.48
11.79%
2.67%
1.00
0.60
60%
UGI
U G I CP
23.64
9.81
11.83%
3.38%
2.41
0.80
33%
NWN
NORTHWEST NAT GAS
42.86
14.83
13.66%
3.87%
2.89
1.66
57%
UMBF
UMB Financial Corporation
38.28
18.23
13.76%
1.93%
2.10
0.74
35%
WMT
WAL MART STORES
53.20
15.60
15.03%
2.05%
3.41
1.09
32%
MON
MONSANTO COMPANY
73.58
19.36
15.93%
1.44%
3.80
1.06
28%
NJR
N J RESOURCES CP
34.99
13.30
16.83%
3.54%
2.63
1.24
47%
BCR
BARD C R INC
80.76
16.18
17.15%
0.84%
4.99
0.68
14%
XOM
EXXON MOBIL CP
72.47
16.89
17.15%
2.32%
4.29
1.68
39%
AWR
AMER ST WATER
32.33
23.95
17.31%
3.22%
1.35
1.04
77%
RLI
R L I CP
50.60
15.86
19.03%
2.13%
3.19
1.08
34%
HGIC
Harleysville Group Inc.
31.21
13.11
19.62%
4.17%
2.38
1.30
55%
SYBT
S.Y. Bancorp, Inc.
21.90
16.22
19.74%
3.11%
1.35
0.68
50%
19 Companies

*NOTE* I added selected regional banks to my watch list. If you are interested, I urge you to do an extensive research prior to your purchase. These regional banks have payout ratio less than or equal to 50%. Next year estimates are expected to rise as well.

Nasdaq 100 Watch List

The following are the Nasdaq 100 members that are within 20% of the 52-week low:

  • Apollo Group, Inc. (APOL) at $55.99 within 1.16%
  • Cephalon, Inc. (CEPH) at $58.26 within 10.87%
  • Genzyme Corporation (GENZ) at $52.28 within 11.02%
  • Pharma. Products Dev. (PPDI) at $20.93 within 16.47%
  • Gilead Sciences, Inc. (GILD) at $46.26 within 17.50%

It is interesting to note the percentage change that has occurred in last week's Nasdaq 100 watch list. Last week's list had the following one week percentage change:

  • APOL down 1.94%
  • CEPH up 6.74%
  • GENZ up 3.32%
  • PPDI down 2.88%
  • GILD up 8.72%
  • BIIB up 8.62%
  • SRCL up 3.69%
  • AMGN up 2%

The biotech/pharma sector is moving higher. As we've stated before, these companies are very undervalued at the present time. Do your research and carefully consider the opportunities. Touc.

Dividend Achiever Watch List

The market is still battling the 10,000 mark and ended the week at 10,023.42, up 3.2% this week. At the end of the week, my watch list shrank to 17 companies compared to 20 from the previous week. Here are the companies on my watch list as of November 6, 2009.
Symbol Name Price P/E % Yr Low Yield EPS Div/Shr Payout Ratio
WTR AQUA AMERICA INC 16.16 20.72 5.00% 3.59% 0.78 0.58 74%
CWT CALIFORNIA WATER 36.32 18.34 8.45% 3.25% 1.98 1.18 60%
MON MONSANTO COMPANY 69.14 18.19 8.93% 1.53% 3.80 1.06 28%
WMT WAL MART STORES 51.25 15.03 10.81% 2.13% 3.41 1.09 32%
PNY PIEDMONT NAT GAS 22.94 14.80 10.93% 4.71% 1.55 1.08 70%
WEYS Weyco Group, Inc. 22.63 20.95 12.53% 2.65% 1.08 0.60 56%
BCR BARD C R INC 78.39 15.71 13.71% 0.87% 4.99 0.68 14%
UGI U G I CP 24.14 10.02 14.19% 3.31% 2.41 0.80 33%
NWN NORTHWEST NAT GAS 43.09 15.61 14.27% 3.85% 2.76 1.66 60%
WGL WGL HOLDINGS INC 33.23 13.90 16.23% 4.42% 2.39 1.47 62%
XOM EXXON MOBIL CP 72.58 16.92 17.33% 2.31% 4.29 1.68 39%
CAH CARDINAL HEALTH 29.50 9.25 18.62% 2.37% 3.19 0.70 22%
NJR N J RESOURCES CP 35.59 13.53 18.83% 3.48% 2.63 1.24 47%
RLI R L I CP 50.60 15.86 19.03% 2.13% 3.19 1.08 34%
FPL F P L GROUP INC 49.76 12.05 19.96% 3.80% 4.13 1.89 46%
PGN PROGRESS ENERGY 37.62 14.53 20.00% 6.59% 2.59 2.48 96%
T AT&T INC. 25.93 12.87 20.94% 6.32% 2.02 1.64 81%
17 Companies






Something to note, I've taken Shenandoah Telecom (SHEN) out because of an annual dividend payment. I feel that it offer less cushion for myself. I replaced this company with Monsanto (MON) which appear to be on its way to becoming part of the Dividend Achiever. Take a look at this report for more on MON.

Investment Observation: Aqua America (WTR)

Today's investment observation is AquaAmerica (WTR). According to Yahoo!Finance's water utilities review, WTR is ranked as the second largest water utility based on market capitalization.The most important point about this investment observation is that WTR has fallen to a brand new low during market hours on Friday October 30th. This low may soon match the 2-year low of around $14.50 set in mid-October 2008. This is fascinating because the actual lowest point after the market peak of 2006 at $30 is no longer on our last 52-week radar. However, we will watch to see if the ultimate low of $14.50 is reached.According to Value Line Investment Survey, WTR normally trades around 1.6 times the per share dividend divided by the "interest rate" (1.6x $0.51/interest rate). Valueline doesn't tell us by which interest rate we should apply to the company, so I have decided to apply the 30, 20, and 10 year U.S. Treasury rate. The following are the mean prices that WTR would trade at for each interest rate:

  • 30 year rate- $19.29
  • 20 year rate- $19.47
  • 10 year rate- $23.93

Based on the 30 year rate, WTR is selling 19.91% below the historical mean value. I chose the $19.29 value since it was the most conservative figure.

However, according to Investment Quality Trends, WTR is considered undervalued when it is selling for $12.27 or less. This indicates that WTR is not currently undervalued but could easily get to the $12.50 range if market conditions continue on the downside. Additionally, WTR has a large debt low and a high dividend payout ratio of 74%. This means that the stock could only "afford" a decline in earnings of 25% before the company has to borrow or issue more share to service the dividend.

According to Dow Theory, the following are the most important downside targets to watch for:

  • $14
  • $11.25 (fair value)
  • $9
  • $6.50

These targets are supposed to act as support levels. Support levels are points which the stock falls to but should not go below. If the stock goes below one support level then we should expect the stock to decline to the next target level.

One support level that is significant is the $15 level. This happens to be the most obvious level that the stock needs to hold above. Falling below $15 could indicate the negative nature of the markets.

Although this is a water utility and water is critical to life, investors need to understand that companies in this industry aren't a "sure thing." The biggest reason for this is that when, and if, water becomes scarce, government regulators will step in to take over (nationalize) what should otherwise be sold at the most profitable price (thereby curbing wasteful consumption.) There is literally an upside cap on profitability to a company like this due to the critical importance of the resource being sold.

Take your time to consider this Dividend Achiever for the good and the bad attributes. Your careful analysis of this company might compel you to purchase the stock. It is my hope that the stock falls further before your next acquisition. Touc.

Related Articles:


Please revisit Dividend Inc. for editing and revisions to this post.

Speculative Observation: Monsanto (MON)

According to Google Finance, "Monsanto Company along with its subsidiaries, is a worldwide provider of agricultural products for farmers. The Company’s seeds, biotechnology trait products, and herbicides provide farmers with solutions to produce foods for consumers and feed for animals. The Company operates in two segments: Seeds and Genomics, and Agricultural Productivity."

Although Monsanto (MON) isn't a Dividend Achiever or a member of the Nasdaq 100, the company has a solid history and provides investors with an exceptional opportunity.

MON is currently trading within 5.85% of the the 52-week low. What is significant about the low that MON is approaching is that it is close to the November 2008 low. This is a critical support level for the stock which could indicate that a major reversal is ahead.

According to Dow Theory, MON is projected to decline to the following levels:

  • $52.17
  • $37.08
  • $21.99
  • $6.90
Each of the downside targets, based on Dow Theory, should provide some kind of support level. Interestingly, MON's 50% level, based on the decline from the prior peak and the July 2002 low, is at $67.90. This means that either the stock declines much further or the stock rebounds from here.

According to Value Investment Survey dated August 2009, MON typically reverts to a level of 17 times cashflow. Full year 2008 cash flow was $4.50 per share. This equals a price of $76.50 that the shares should revert to at some point in the future. Value Line seems to believe that, for 2009, MON should achieve cash flow of $5.55 per share which implies a mean price of $94.35. I would opt for the lower price just to play it safe. In the period from 1981 to 1996, Value Line had a smaller mean price to cash flow (13x). This means that as time has gone on since 81' to 96' MON has managed to improve their price to cash flow figures.

With MON trading at 11% below the historical mean value, as well as being within 6% of the low, this is a good opportunity to get your research in as the share price declines. Focus on the downside risk and good luck. Touc.

Follow-up article:

Nasdaq 100 Watch List

The following are the Nasdaq 100 members that are within 20% of the 52-week low:

  • Apollo Group, Inc. (APOL) at $57.10 within 3.16%
  • Cephalon, Inc. (CEPH) at $54.58 within 3.86%
  • Genzyme Corporation (GENZ) at $50.60 within 7.45%
  • Gilead Sciences, Inc. (GILD) at $42.55 within 8.08%
  • Biogen Idec Inc (BIIB) at $42.13 within 13.22%
  • Stericycle, Inc. (SRCL) at $52.37 within 18.06%
  • Amgen Inc. (AMGN) at $53.62 within 19.26%
  • Pharmaceutical Product Developm (PPDI) at $21.55 within 19.92%

The fact that all of these companies (except for APOL) are within the drug industry does not surprise me. The continued undervaluation of these companies makes them prime targets for acquisition by investors and larger drug companies. Touc.

Dividend Achiever Watch List

The market appeared to be losing the 10,000 mark battle. The Dow lost 259.6 points (-2.6%) this week. At the end of the week, my watch list expanded to 21 companies compared to 15 from the previous week. Here are the companies on my watch list as of October 30, 2009.

Symbol Name Price P/E % Yr Low Yield EPS Div/Shr Payout Ratio
WTR AQUA AMERICA INC 15.45 19.81 0.00% 3.75% 0.78 0.58 74%
SHEN Shenandoah Telecom 16.69 26.49 0.91% 1.92% 0.63 0.32 51%
WMT WAL MART STORES 49.68 14.57 7.42% 2.19% 3.41 1.09 32%
BCR BARD C R INC 75.07 15.04 8.89% 0.91% 4.99 0.68 14%
CWT CALIFORNIA WATER SVC 36.57 17.33 9.20% 3.23% 2.11 1.18 56%
NWN NORTHWEST NAT GAS 41.81 15.15 10.87% 3.97% 2.76 1.66 60%
WEYS Weyco Group, Inc. 22.30 20.65 10.89% 2.69% 1.08 0.60 56%
PNY PIEDMONT NAT GAS CO 23.28 15.02 12.57% 4.64% 1.55 1.08 70%
UGI U G I CP 23.88 9.91 12.96% 3.35% 2.41 0.80 33%
CAH CARDINAL HEALTH INC 28.34 8.88 13.95% 2.47% 3.19 0.70 22%
WGL WGL HOLDINGS INC 33.06 13.83 15.63% 4.45% 2.39 1.47 62%
XOM EXXON MOBIL CP 71.67 11.50 15.86% 2.34% 6.23 1.68 27%
MCD MCDONALDS CP 58.61 15.14 16.20% 3.75% 3.87 2.20 57%
NJR N J RESOURCES CP 35.20 13.38 17.53% 3.52% 2.63 1.24 47%
BDX BECTON DICKINSON CO 68.36 14.18 17.58% 1.93% 4.82 1.32 27%
FPL F P L GROUP INC 49.10 10.37 18.37% 3.85% 4.74 1.89 40%
SJW S J W CP 21.77 23.92 19.48% 3.03% 0.91 0.66 73%
PGN PROGRESS ENERGY INC 37.53 13.08 19.71% 6.61% 2.87 2.48 86%
T AT&T INC. 25.67 12.71 19.73% 6.39% 2.02 1.64 81%
AWR AMER ST WATER 33.15 24.56 20.28% 3.02% 1.35 1.00 74%
21 Companies

Nasdaq 100 Watch List

It is the firm belief of the New Low Observer team that anyone who does not investigate and acquire at least one of these stocks is, in our opinion, missing the sale of the decade. While the debate about nationalized healthcare begins to wane, there will be a palatable realization that the medical sector was unduly suppressed. Below I will feature BIIB and GILD. However, let's look at the Nasdaq 100 stocks that are within 20% of their 52-week low.

Nasdaq 100 Watch List (Yahoo!Quote Summary View):

  • Stericycle (SRCL) at $53.17
  • Gilead Sciences (GILD) at $43.83
  • Genzyme Corp. (GENZ) at $54.50
  • Cephalon, Inc. (CEPH) at $54.02
  • Biogen Idec (BIIB) at $43.81
Today’s watch list has the addition of Biogen Idec (BIIB). According to Valueline, BIIB has a historical mean price-to-cash flow of 12x. Based on the 2008 per share cash flow of $4.31, BIIB should revert, at some point, to the mean price of $51.72. At $43.81, BIIB is trading 18% below the mean price.

Below is the Coppock Curve for Gilead Sciences (GILD). The Coppock Curve is intended to provided the best risk-adjusted buy signal. If you review the price of the stock and have a short time frame, the buy signals were, at times, alarmingly accurate.

Using Yahoo!Finance's long term chart for GILD, we see the following prices for the above buy signals:

  • May 1994 at $0.48
  • Jan 1997 at $2.03
  • Aug 1998 at $1.14
  • July 2009 at $48.93

The fact that the stock trades below the July buy signal bodes well for those willing to investigate the qualitative elements of GILD. Touc.

Disclosure: Long CEPH

Dividend Achiever Watch List

The market was fighting hard at the 10,000 range but settled below that mark at the end of the week. The Dow gained 24 points (0%) this week. At the end of the week, my watch list expanded to 15 companies compared to 11 from the previous week. Here are the companies on my watch list as of October 23, 2009.

Symbol Name Price P/E % Yr Low Yield EPS Div/Shr Payout Ratio
SHEN Shenandoah Telecom 16.81 26.68 1.63% 1.90% 0.63 0.32 51%
WMT WAL MART STORES 50.44 14.79 9.06% 2.16% 3.41 1.09 32%
BCR BARD C R INC 76.74 16.09 11.31% 0.89% 4.77 0.68 14%
WEYS Weyco Group, Inc. 22.44 20.78 11.59% 2.67% 1.08 0.60 56%
WTR AQUA AMERICA INC 15.89 20.37 13.50% 3.65% 0.78 0.58 74%
NWN NORTHWEST NAT GAS 43.02 15.59 14.08% 3.86% 2.76 1.66 60%
PNY PIEDMONT NAT GAS
23.72 15.30 14.70% 4.55% 1.55 1.08 70%
CAH CARDINAL HEALTH
28.66 8.98 15.24% 2.44% 3.19 0.70 22%
BDX BECTON DICKINSON
67.50 14.00 16.10% 1.96% 4.82 1.32 27%
MCD MCDONALDS CP 59.43 15.76 17.82% 3.70% 3.77 2.20 58%
XOM EXXON MOBIL CP 73.57 11.80 18.93% 2.28% 6.23 1.68 27%
T AT&T INC. 25.73 12.74 20.01% 6.37% 2.02 1.64 81%
PGN PROGRESS ENERGY
37.68 13.13 20.19% 6.58% 2.87 2.48 86%
RLI R L I CP 51.11 23.66 20.23% 2.11% 2.16 1.08 50%
NJR N J RESOURCES CP 36.02 13.70 20.27% 3.44% 2.63 1.24 47%

15 Companies

Speculation Observations: Mattson Technology (MTSN) at $2.65

Mattson Technology (MTSN) is a supplier of equipment to Semiconductor producers (i.e. Intel). Some of their competitors are Applied Materials (AMAT), Lam Research (LRCX), and Novellus (NVLS). These are 2 billion dollar plus companies versus a 130 million dollar company. Market cap doesn't tell me anything about valuation of the company, so I would ignore that figure for now.
Macro View
When the economy recovers, people feel better and they go out and buy a computer from suppliers like Dell or HP. These computer suppliers then have to ramp up their production and order more computer chips from Intel or Samsung. A demand surge triggered Intel to boost production by expanding their production capacity by purchasing more tools from the likes of Applied Materials or Mattson. This is what generally happens when the economy recovery takes place.
Market Exposure
In 2008, 19% of MTSN revenue came from Canon and 10% came from Samsung (from 2008 Annual Report). Because 90% of MTSN's revenue comes from overseas, this company is truly international company. The largest market they served is memory, which is estimated to be around 70% of their revenue. As you may guessed from going to Fry's or Best Buy, USB memory sticks sell for next to nothing. It's appropriate that this market has seen a fair share of margin contraction (lower profit). This may be the reason why the share price of Mattson and its competitors who are exposed to memory got cut in half.
Valuation
Mattson is currently trading around the $2.50 to $3.00 range. They hold $1.56 cash per share and $2.24 book value. As a result, you have a tech company with NO DEBT, trading at roughly 1.2x book value. That fits Benjamin Graham's formula. Tangible book value (this exclude IP value) is at $3.16 at the end of 2008. Because the company has negative earnings and no dividends, we can only assess valuation based on book value. Using Morningstar valuation tool, you see that over the prior of 10 years, the average trough book value is 1.2.
Some of the things I am concern about are negative earnings for this year and the next, possible burn in cash flow, and market liquidity issues. The company traded as high as $11.76 in 2007 then dropped to $0.30 in 2008. Assuming that you bought at the low and sold at $2.50, you would have gained 700%+ on your money. Such extreme low valuation will not likely return because the credit market have recovered somewhat.
So how do I come up with a fair market value for Mattson? Simple calculation based on Dow Theory suggest a fair market price of $6.03. The calculation is simple, take the peak price of $11.76, plus the absolute low of $0.30, then divide it by 2. That's the fair market value based on the Dow Theory interpretation. The chart below shows a graphical representation of from the peak to the most recent trough.
What You Need to Buy?
If you plan on buying MTSN as a speculation, here are things you need.
  • Strong and Healthy Heart for the up and down market. Don't be surprised if the price falls to $1.50 range.
  • Money you can "throw away". This is a speculation at best, so make sure you can lose it and still be ok.
  • Time. This company will need time to work through the current economic environment. It is safest to assume that the price will not revert to $6 simply because I wrote about it. The market will decide that.
Once again, this observation is on the deep end of the speculation pool. I've selected a stock that I believe has a lot more room on the upside but downside should be apparent based on the $0.30 low. Please do your homework and manage this speculation wisely.
Art

Disclosure: None

Follow-up Article:

Nasdaq 100 Watch List

This week the New Low Observer highlights four companies in the Nasdaq 100 that are within 20% of their 52-week low.
  • Cephalon Inc. (CEPH) at 3.56% above their 52-week low.
  • Gilead Sciences (GILD) at 17.27% above their 52-week low.
  • Stericycle (SRCL) at 17.76% above their 52-week low.
  • Genzyme Corp. (GENZ) at 18.79% above their 52-week low.

Cephalon (CEPH), according to Valueline, normally trades at 12 times cashflow. The cashflow for CEPH in 2007 was $5.41 per share (Mergent’s, was $5.78 for 2007.) Using the smaller figure, we get a price of $64.92 as the average price that the stock has typically reverted to. As the number of shares for CEPH have increased by 11% since 2007, I have adjusted lower the cash flow per share by 11% as a rough gauge of what the historical average price would be at 12x cash flow. The figure that I come up with is $57.72. This is 5.71% above the current price of $54.42. Valueline sees the negative cashflow figures persisting until the foreseeable future. (I have intentionally left out the negative cashflow figures for 2008 because the economy was in recession for the whole year.)

Gilead Sciences (GILD), according to Valueline, should be trading at 20x cashflow. With a cashflow of $2.32 in 2008, GILD averages a price of $46.40. Although Mergent’s has a cashflow figure that is higher, I will go with the most conservative figure that I can find. At the current price of $46.17, GILD is trading at the historical cashflow. Maybe this is a fading star but GILD has never traded below 20x cashflow for an extend period of time.

Based on 2008 cashflow figures from Valueline, Stericycle (SRCL) would trade around the $38.18 range. The 2008 cashflow for SRCL was $2.19 per share. This is significantly above the mean, which makes these share less inviting even though they are within 18% of the 52-week low.

Finally we have Genzyme Corp. (GENZ) at $55.94. This stock has historically traded at 19 times cashflow. The 2008 cashflow for this GENZ was $2.82, according to Mergent’s (Valueline had the higher figure.) GENZ, although selling 19% above the 52-week low, is a far superior value proposition. The shares outstanding have grown by 2.7% from 2006 to 2008 while the long-term debt has fallen by 85% over the same time frame.

Additional analysis will be provided on these companies as long as they stay within 20% of the 1-year low. Touc.

Disclosure: Long CEPH

Dividend Achiever Watch List

The market put on a bull horn and marched passed 10,000 but settled below that mark at the end of the week. The Dow gained 130 points (1.3%) this week.

We're mid way through October and if you recall the same time last year, this marked the beginning of the market freefall. As a result, many companies with their low mark have been pushed up by the moving 52-week range. At the end of the week, my watchlist expanded to 11 companies compared to 9 from the previous week. Here are the companies on my watch list as of October 16, 2009.

Symbol
Name
Price
P/E
% Yr Low
Yield
EPS
Div/Shr
Payout Ratio
SHEN
Shenandoah Telecom
16.81
26.68
1.63%
1.78%
0.63
0.30
48%
BCR
BARD C R INC
76.19
15.98
10.52%
0.89%
4.77
0.68
14%
WMT
WAL MART STORES
51.22
15.02
10.75%
2.13%
3.41
1.09
32%
WEYS
Weyco Group, Inc.
22.40
20.74
11.39%
2.68%
1.08
0.60
56%
NWN
NORTHWEST NAT GAS
43.39
15.72
15.06%
3.83%
2.76
1.66
60%
CAH
CARDINAL HEALTH
28.68
8.99
15.32%
2.44%
3.19
0.70
22%
MCD
MCDONALDS CP
58.78
15.58
16.53%
3.74%
3.77
2.20
58%
PNY
PIEDMONT NAT GAS CO
24.19
15.61
16.97%
4.46%
1.55
1.08
70%
WTR
AQUA AMERICA INC
16.65
21.35
18.93%
3.48%
0.78
0.58
74%
BDX
BECTON DICKINSON CO
69.26
14.37
19.13%
1.91%
4.82
1.32
27%
T
AT&T INC.
25.70
12.72
19.87%
6.38%
2.02
1.64
81%
11 Companies

Dividend Achiever Watch List

The market snapped out of the downtrend with force this week. The Dow gained 376 points or 4% this week. At the end of the week, our Dividend Achiever watch list has 9 companies compared to 12 from the previous week. Here are the companies on our watch list as of October 9, 2009.

Symbol
Name
Price
P/E
% Yr Low
Yield
EPS (ttm)
Div/Shr
Payout Ratio
WMT
WAL MART STORES
49.97
14.65
8.04%
2.18%
3.41
1.09
32%
CAH
CARDINAL HEALTH INC
27.32
8.56
9.85%
2.56%
3.19
0.70
22%
WEYS
Weyco Group, Inc.
22.65
20.97
12.63%
2.65%
1.08
0.60
56%
BCR
BARD C R INC
77.94
16.35
13.05%
0.87%
4.77
0.68
14%
PNY
PIEDMONT NAT GAS CO
23.73
15.31
15.64%
4.55%
1.55
1.08
70%
NWN
NORTHWEST NAT GAS
42.43
15.37
15.90%
3.91%
2.76
1.66
60%
BDX
BECTON DICKINSON CO
68.75
14.27
18.25%
1.92%
4.82
1.32
27%
PGN
PROGRESS ENERGY INC
37.45
13.05
19.46%
6.62%
2.87
2.48
86%
MKC
MCCORMICK & CO
33.67
16.75
19.91%
2.85%
2.01
0.96
48%
9 companies
Becton Dickinson (BDX) is still on this list and the price hasn't move much since Buffett announced back in August that he took a stake in the company. It may be worth reconsidering BDX based on the current lack of "action." Art.

Note: Abbott Lab (ABT) is no longer on this list after being on it since this list began in June. I flagged you to ABT on 9/24/09 and the stock has gained 8.5% since.

A Second Look at Cephalon Inc. (CEPH)

Speculative Observation
It is just our luck that Cephalon Inc. (CEPH) did exactly what we thought would happened based on the chart pattern in our August 27, 2009 article. In that posting, we said that we thought that Cephalon would experience a price breakout starting on the September 5th. The bias that we had in the article was clearly in favor of a stock price rise in the breakout formation. Part of our justification for this was due in part, on the fact that CEPH was, according to our metrics, relatively undervalued. However, we didn't know when and by how much the stock would rise.

On September 21st, Cephalon rose to an intraday high of $69.30, far exceeding our expectations for the stock in the short term. Because this stock does not pay a dividend we could not make a recommendation of this company as an investment observation. It appears that the speculative observation that we gave was appropriate for the recent moves in the price. However, the stock is now approaching the 52-week low again.
Below are the revised figures for the Dow Theory downside targets (since the upside takes care of itself):
  • $40
  • $31.66
  • $14.40
  • $6

For the reasons above, we highly recommend that you re-consider the article written on August 27th. With a $4 billion market cap, this stock should be among your choices of new speculative opportunities. Art and Touc.